|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 2018 Chinese Guidelines for Prevention and Treatment of Hypertension——A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension显示文摘Table of Contents Preamble 1 Prevalence of hypertension in Chinese population 1.1 Prevalence,incidence and epidemic trend of hypertension in Chinese population 1.2 Awareness,treatment and control of Hypertension in China 1.3 Important risk factors for hypertension in Chinese population 2 Hypertension and cardiovascular risk 2.1 Relationship between blood pressure and cardiovascular risk 2.2 Cardiovascular risk characteristics of hypertension population in China 3 Diagnostic evaluation 3.1 Medical history 3.2 Physical examination 3.3 Laboratory examinations 3.4 Genetic analysis 3.5 BP measurement 3.6 Evaluation of target organ damage. | Joint Committee for Guideline Revision Chinese Hypertension League Chinese Society of Cardiology Hypertension Committee of the Chinese Medical Doctor Association Hypertension Branch of the China Association for the Promotion of International Exchanges of Health Care Hypertension Branch of the Chinese Geriatrics Society Li–Sheng LIU | 2019 | Journal of Geriatric Cardiology2019，16，3： | 95 |
| 2 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders:executive summary and 2019 update of clinical management of stroke rehabilitation显示文摘Stroke is the third leading cause of long-term disability.Effective stroke rehabilitation should be provided to patients with a moderate or severe stroke so as to achieve functional recovery.Also,stroke rehabilitation is moving towards more intense therapy models that incorporate technologies such as robotics and computer games.Evidence-based guidelines are useful for promoting the best possible clinical practices.This guideline summarises the modes of stroke rehabilitation in China-three-stage rehabilitation network,rehabilitation of stroke dysfunction,training for activities of daily living,stroke complications and rehabilitation care.The aim of this guideline was to provide a synopsis of best clinical practices in the stroke rehabilitation of adult patients in China. | Tong Zhang Jun Zhao Xueping Li Yulong Bai Baojun Wang Yun Qu Bingjie Li Shengjie Zhao Chinese Stroke Association Stroke Council Guideline Writing Committee | 2020 | Stroke & Vascular Neurology2020，5，3： | 38 |
| 3 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis显示文摘Aim Cerebral venous sinus thrombosis(CVST)is a less common cerebrovascular disease that predominantly affects young patients.The incidence of CVST is 2-5/10000000/year,accounting for 0.5%-1%of all stroke.To reduce mortality and morbidity associated with CVST,Chinese Stroke Association commissioned the authors to write the current guideline on the management of CVST.Methods PubMed(MEDLINE),CNKI and Wanfang database were searched for studies related to CVST from 1 January 1990 to 31 July 2019.Data were synthesised by evidence tables.Each recommendation was fully discussed by the writing group members and reviewed by Chinese Stroke Association Stroke Fellow Committees.Levels of evidence grading algorithm of Chinese Stroke Association was used to grade each recommendation.results This guideline mainly focuses on the diagnostic evaluation,therapeutic strategies and secondary prevention of CVST.CT/CTV and MRI/MRV are recommended in the initial imaging evaluation of patients with suspected CVST.Anticoagulation therapy with low-molecular weight heparin should be initiated in patients with CVST immediately.After the acute stage,warfarin is recommended for 3-6 months to prevent the recurrence of CVST and other venous thromboembolic events.Conclusions The guideline summarises the current evidence regarding the management of CVST,and provides references for diagnosis,treatment and secondary prevention of CVST in China. | Yuhua Fan Jian Yu Hongbing Chen Jian Zhang Jiangang Duan Dapeng Mo Wenhao Zhu Bo Wang Fubing Ouyang Yicong Chen Linfang Lan Jinsheng Zeng Chinese Stroke Association Stroke Council CVST Guideline Writing Committee | 2020 | Stroke & Vascular Neurology2020，5，2： | 14 |
| 4 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders:executive summary and 2019 update of the management of high-risk population显示文摘Aim Cerebrovascular disease is the leading cause of death and disability in China,causing a huge burden among patients and their families.Hence,stroke prevention is critical,especially in the high-risk population.Here,we present the evidence-based guideline suitable for the Chinese population.Methods Literature search of PubMed and Cochrane library(from January 1964 to June 2019)was done.After thorough discussion among the writing group members,recommendations were listed and summarised.This guideline was reviewed and discussed by the fellow writing committees of the Chinese Stroke Association’s Stroke.Results This evidence-based guideline was written in three parts:controlling the risk factors of stroke,utilisation of antiplatelet agents and assessing the risks of first-ever stroke.All recommendations were listed along with the recommending classes and levels of evidence.Conclusions This guideline provides recommendations for primary prevention of cerebrovascular disease among high-risk population in China.Controlling related risk factors,appropriately using antiplatelet agents,assessing the risk of developing first-ever stroke should help reduce the rate of cerebrovascular disease in China. | Yilong Wang Shangrong Han Haiqiang Qin Huaguang Zheng Bin Jiang Yong Cao Yuan Gao Ling Guan Qian Jia Yong Jiang Yuming Jiao Shuya Li Yapeng Li Zixiao Li Wei Liu Xiaojuan Ru Dongling Sun Haixin Sun Penglian Wang Tingting Wang Lixia Zong Lei Guo Xuewei Xie Yuming Xu Yuyuan Xu Xiaomeng Yang Yingying Yang Mengyuan Zhou Wenzhi Wang Chinese Stroke Association Stroke Council Guideline Writing Committee | 2020 | Stroke & Vascular Neurology2020，5，3： | 11 |
| 5 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders:executive summary and 2019 update on organizational stroke management显示文摘Aim Stroke is characterised by high morbidity,mortality and disability,which seriously affects the health and safety of the people.Stroke has become a serious public health problem in China.Organisational stroke management can significantly reduce the mortality and disability rates of patients with stroke.We provide this evidence-based guideline to present current and comprehensive recommendations for organisational stroke management.Methods A formal literature search of MEDLINE(1 January 1997 through 30 September 2019)was performed.Data were synthesised with the use of evidence tables.Writing group members met by teleconference to discuss data-derived recommendations.The Chinese Stroke Association’s Levels of Evidence grading algorithm was used to grade each recommendation.results Evidence-based guidelines are presented for the organisational management of patients presenting with stroke.The focus of the guideline was subdivided into prehospital first aid system of stroke,rapid diagnosis and treatment of emergency in stroke centre,organisational management of stroke unit and stroke clinic,construction of regional collaborative network among stroke centres and evaluation and continuous improvement of stroke medical quality.Conclusions The guidelines offer an organisational stroke management model for patients with stroke which might help dramatically. | Min Lou Jing Ding Bo Hu Yusheng Zhang Hao Li ZeFeng Tan Yan Wan An-Ding Xu Chinese Stroke Association Stroke Council Guideline Writing Committee | 2020 | Stroke & Vascular Neurology2020，5，3： | 7 |
| 6 | 指南 成人原发及转移性脑肿瘤:NICE指南概要显示文摘原发恶性脑肿瘤虽然仅占癌症总数的3%,但其生存预后在所有癌症中却是最差的。尽管诊治水平有所改善,但恶性脑肿瘤的存活率依然很低(表1);人们认为通过制定全国统一实行的规范化指南,可延长患者寿命并改善生活质量。超过60%原发性脑肿瘤患者的初次诊断不是由全科医生或专科医生做出的,而是偶然发现的,或是在急诊就诊中发现的。在初级医疗中,最常见的脑肿瘤是脑转移瘤,当然也有其他类型脑肿瘤。 | Alex Bates Garth Cruickshank Tom Roques Guideline Committee 徐菲(译) 王燕(校) | 2018 | 英国医学杂志中文版2018，21，11： | 3 |
| 7 | Guidelines on clinical research evaluation of artificial intelligence in ophthalmology(2023)显示文摘With the upsurge of artificial intelligence(AI)technology in the medical field,its application in ophthalmology has become a cutting-edge research field.Notably,machine learning techniques have shown remarkable achievements in diagnosing,intervening,and predicting ophthalmic diseases.To meet the requirements of clinical research and fit the actual progress of clinical diagnosis and treatment of ophthalmic AI,the Ophthalmic Imaging and Intelligent Medicine Branch and the Intelligent Medicine Committee of Chinese Medicine Education Association organized experts to integrate recent evaluation reports of clinical AI research at home and abroad and formed a guideline on clinical research evaluation of AI in ophthalmology after several rounds of discussion and modification.The main content includes the background and method of developing this guideline,an introduction to international guidelines on the clinical research evaluation of AI,and the evaluation methods of clinical ophthalmic AI models.This guideline introduces general evaluation methods of clinical ophthalmic AI research,evaluation methods of clinical ophthalmic AI models,and commonly-used indices and formulae for clinical ophthalmic AI model evaluation in detail,and amply elaborates the evaluation methods of clinical ophthalmic AI trials.This guideline aims to provide guidance and norms for clinical researchers of ophthalmic AI,promote the development of regularization and standardization,and further improve the overall level of clinical ophthalmic AI research evaluations. | Wei-Hua Yang Yi Shao Yan-Wu Xu Expert Workgroup of Guidelines on Clinical Research Evaluation of Artificial Intelligence in Ophthalmology(2023) Ophthalmic Imaging and Intelligent Medicine Branch of Chinese Medicine Education Association Intelligent Medicine Committee of Chinese Medicine Education Association | 2023 | International Journal of Ophthalmology(English edition)2023，16，9： | 2 |
| 8 | 2003 European society of hypertension european society of cardiology guidelines for the management of arterial hypertension显示文摘 | European Society of Hyertension European Society of Cardiology Guidelines Committee | 2003 | Hypertens2003，21，6： | 1 |
| 9 | 1999 World Health Orgnization International Society of hypertensive guidelines for the management of hypertension显示文摘 | WHO/ISH Guidelines Committee | 1999 | Blood Press Suppl1999，1，： | 1 |
| 10 | 1999 WHO/ISH Guideline for the management of hypertension显示文摘 | WHO/ISH Hypertension Guideline Committee | 1999 | Hypertension1999，17，2： | 1 |
| 11 | 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension 显示文摘 | European Society of Hypertension-European Society of Cardiology Guidelines Committee | 2003 | J Hypertens2003，21，6： | 1 |
| 12 | British Thoracic Society guide- lines for the management of suspected acute pulmonary embolism 显示文摘 | British Thoracic Society Standards of Care Committee Pulmonary Em- bolism Guideline Development Group | 2003 | Thorax2003，58，： | 1 |
| 13 | APIC guidelines for infection control praetiee:APIC guidelines for handwashing and hand antisepsis in healthcare settings 显示文摘 | Lason EL and the 1992 1993 and 1994 APIC Guidelines Committee | 1995 | AM J infect Control1995，23，： | 1 |
| 14 | 1999 world health organization-international society of hypertension guidelines for the management of hypertension显示文摘 | WHO-ISH hypertension guidelines committee | 1999 | J Hypertension1999，17，： | 1 |
| 15 | 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension显示文摘 | European Society of Hypertension-European Society of Cardiology Guidelines Committee | 2003 | J Hypertens2003，21，6： | 1 |
| 16 | 2013ACCF/AHA Guideline for the Man- agement of ST-Elevation Myocardial Infarction: Executive Summary : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 显示文摘 | 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocar- dial Infarction: Executive Summary Writing Committee members | 2013 | Circulation2013，127，4： | 1 |
| 17 | 1999 World Health Organization- International Society of Hypertension Guidelines for the Management of Hypertension 显示文摘 | WHO-ISH Hypertension Guidelines Committee | 1999 | J Hypertens1999，17，2： | 1 |
| 18 | 1999 World Health Or-ganization International society of hypertension guidelines for the management of hypertension 显示文摘 | | 1999 | J Hypertens1999，17，： | 1 |
| 19 | European Society of Cardiology Guidelines for the management of arterial hypertension显示文摘 | European Society of Cardiology Guidelines Committee | 2003 | Hypertens2003，21，6： | 1 |
| 20 | Chronic Hepatitis B:Update of Recommendations显示文摘 | Lok ASF McMahon BJ Practice Guidelines Committee American Association for the Study ofLiver Diseases(AASLD) | 2004 | Hepatology2004，39，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员